I’m pretty disappointed in the voting here. The company has sizeable and growing revenue that is several orders of magnitude better than anything else we’ve evaluated including Glycanage, etc. (I love GlycanAge but have to be fair). It’s a Ycombinator company run by 3 highly industrious technical founders. I think we are missing out on a sure bet with highly practical form of gene therapy. The science can come. It wouldn’t be hard.
Boston Matrix has unanimous 16 upvotes and no downvotes, meaning it is ready for on-chain voting but Zbiotics won’t??? . I think this shows the limitation of our govenance.